New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
10:00 EDTVLP, PSXP, JAZZ, ARIA, ITMN, FST, VNO, TOL, NIHD, HUM, DWA, SEAC, IZEA, VLRS, SWY, JNPR, FMS, SUNS, NEM, MSO, BOOM, DRHOn The Fly: Analyst Downgrade Summary
DiamondRock (DRH) downgraded to Neutral from Buy at ISI Group... Dynamic Materials (BOOM) downgraded to Neutral from Overweight at JPMorgan... Fresenius Medical (FMS) downgraded to Neutral from Buy at UBS... Humana (HUM) downgraded to Sell from Neutral at Citigroup... Jazz Pharmaceuticals (JAZZ) downgraded to Hold from Buy at Cantor... Juniper (JNPR) downgraded to Neutral from Overweight at Piper Jaffray... NII Holdings (NIHD) downgraded to Neutral from Outperform at Macquarie... Phillips 66 Partners (PSXP) downgraded to Neutral from Outperform at Credit Suisse... Safeway (SWY) downgraded to Neutral from Overweight at JPMorgan... Toll Brothers (TOL) downgraded to Market Perform from Outperform at Keefe Bruyette... Valero Energy Partners (VLP) downgraded to Neutral from Outperform at Credit Suisse... Volaris (VLRS) downgraded to Hold from Buy at Deutsche Bank... Vornado (VNO) downgraded to In-Line from Outperform at Imperial Capital... Martha Stewart (MSO) downgraded to Hold from Buy at Noble Financial... IZEA (IZEA) downgraded to Neutral from Buy at Merriman... Forest Oil (FST) downgraded to Market Perform from Outperform at Wells Fargo... Newmont Mining (NEM) downgraded to Hold from Buy at Argus... SeaChange (SEAC) downgraded to Neutral from Buy at Dougherty... InterMune (ITMN) downgraded to Market Perform from Outperform at Leerink... Solar Senior Capital (SUNS) downgraded to Hold from Buy at BB&T... DreamWorks Animation (DWA) downgraded to Underweight from Neutral at Piper Jaffray... ARIAD (ARIA) downgraded to Neutral from Buy at Chardan.
News For DRH;BOOM;FMS;HUM;JAZZ;JNPR;NIHD;PSXP;SWY;TOL;VLP;VLRS;VNO;MSO;IZEA;FST;NEM;SEAC;ITMN;SUNS;DWA;ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 10, 2014
05:31 EDTTOLToll Brothers expects to deliver 5,000-6,000 homes in FY15
Subscribe for More Information
05:25 EDTTOLToll Brothers reports Q4 EPS 71c, consensus 73c
Subscribe for More Information
December 9, 2014
21:40 EDTDWADreamWorks Animation to launch kids and family channel across Asia
Subscribe for More Information
15:18 EDTTOLNotable companies reporting before tomorrow's open
Subscribe for More Information
10:23 EDTJNPROn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:23 EDTDWAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTARIAARIAD takeover rumors rekindled, Independent says
Subscribe for More Information
08:31 EDTJAZZJazz, Concert say Phase 1 JZP-386 evaluation not done at highest dosage
Subscribe for More Information
07:37 EDTARIAARIAD announces safety, efficacy follow-up data on Iclusig
Subscribe for More Information
07:36 EDTARIAARIAD says Iclusig shows anti-leukemic activity in long-term follow up data
ARIAD Pharmaceuticals announced long-term follow up data from the Phase 1 trial of Iclusig, its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. The study now shows that with a median follow-up of four years in chronic phase CML patients, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options and that responses have been maintained in CP-CML patients with 72 percent having a major cytogenetic response, 65 percent having a complete cytogenetic response and 56 percent having a major molecular response. Long-term safety data show that careful benefit-risk evaluations should guide decisions to use and maintain ponatinib therapy, particularly in patients who may be at increased risk for arterial thrombotic events. These data were featured in a poster presentation on December 8 at the 56th Annual Meeting of the American Society of Hematology taking place in San Francisco.
07:22 EDTJNPRBMO Capital to hold a conference
Subscribe for More Information
06:39 EDTJNPRJuniper initiated with a Neutral at Wedbush
Subscribe for More Information
06:10 EDTFSTForest Oil receives continued listing standards notice from NYSE
Subscribe for More Information
06:03 EDTDWADreamWorks Animation downgraded to Sell from Hold at Topeka
December 8, 2014
10:20 EDTDWAOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTSEACOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:43 EDTSEACSeaChange downgraded to Hold from Strong Buy at BWS Financial
Subscribe for More Information
07:36 EDTARIAARIAD: Iclusig demonstrates anti-leukemic activity in patents in Phase 2 trial
Subscribe for More Information
07:29 EDTJAZZUBS to hold investor trip
Subscribe for More Information
07:18 EDTJAZZUBS to hold investor trip
2014 Annual West Coast Investor Trip travels on the West Coast on December 8-10.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use